Modified Asthma Predictive Index (mAPI)

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۵۰ • واحد: episodes/year

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
mapi result
—result
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • ——
  • ——
Direct Clinical Answer

The Modified Asthma Predictive Index (mAPI) calculates predicting future asthma onset probability in pediatric patients ≤3 years old with recurrent wheezing episodes. Key inputs include wheezing episodes per year. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Predicts future asthma onset probability in pediatric patients ≤3 years old with recurrent wheezing episodes

Clinical Indication

The Modified Asthma Predictive Index (mAPI) is indicated for bedside clinical practice to support Predicts future asthma onset probability in pediatric patients ≤3 years old with recurrent wheezing episodes. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.

Limitations & Contraindications

Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.

Clinical Pearls & Action Plan

Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice. Guideline pearl: High specificity (98-100%) but variable sensitivity (8.2-19%).

Formula & Variables:

mAPI positive if: ≥4 wheezing episodes per year AND (≥1 major criteria OR ≥2 minor criteria). Major criteria: parent asthma, atopic dermatitis, aeroallergen sensitivity. Minor criteria: wheezing unrelated to colds, eosinophils ≥4%, food allergies.

Input Parameters

NameTypeRequiredDescription
wheezing_episodes_per_yearintegerYesNumber of wheezing episodes per year (≥4 required for mAPI applicability)(episodes/year)
parent_asthmastringYesParent has asthma (major criteria)
atopic_dermatitisstringYesPatient has physician-diagnosed atopic dermatitis (major criteria)
aeroallergen_sensitivitystringYesPatient has demonstrated aeroallergen sensitivity through skin tests or blood tests (major criteria)
wheezing_unrelated_coldsstringYesWheezing unrelated to colds (minor criteria)
eosinophils_4_percentstringYesEosinophils ≥4% on complete blood count (minor criteria)
food_allergiesstringYesDocumented allergy to milk, egg, or peanuts (minor criteria)

Score Interpretation & Guidance

RangeStageDescription
——Negative mAPI
——Positive mAPI

Evidence-Based References (EBM)

  • Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006 May 11;354(19):1985-97. doi: 10.1056/NEJMoa051378.DOI: 10.1056/NEJMoa051378
  • Chang TS, Lemanske RF, Guilbert TW, Gern JE, Coen MH, Evans MD, et al. Evaluation of the modified asthma predictive index in high-risk preschoolers. J Allergy Clin Immunol Pract. 2013 Mar-Apr;1(2):152-6. doi: 10.1016/j.jaip.2012.10.008.DOI: 10.1016/j.jaip.2012.10.008
  • Castro-Rodríguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1403-6. doi: 10.1164/ajrccm.162.4.9912111.DOI: 10.1164/ajrccm.162.4.9912111

Related calculators